| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca8fdd1e3f6083c097539d5934605010
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_811bf9e3b0e97af7086a1f9f911f9ea6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-342
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2570-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2560-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-4833 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2013-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa364f360a20febbaf575fea6076b59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e607f44ea8768904336c8b058b7bc87b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_344e45ca6406f86b71819cd4639fddaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb9fbb1d4535e523b26201e80159c531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e5301d4e418faafdabcac89c989860d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7752a1feacce339528c0539af6f9a82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a07ace7c68773aa153824ecfd884dde9 |
| publicationDate |
2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014053564-A1 |
| titleOfInvention |
Means and methods for diagnosing recurrence of prostate cancer after prostatectomy |
| abstract |
The present invention concerns means and methods for cancer diagnosis and, in particular, diagnosis of prostate cancer. Specifically, it relates to a method for diagnosing whether a sub¬ ject is at risk for recurrent prostate carcinoma after prostatectomy comprising determining the amount of at least one metabolite selected from Table 2 in a test sample of a subject after pros¬ tatectomy, and comparing the determined amount to a reference, whereby it is diagnosed whether the subject is at risk for recurrent prostate carcinoma after prostatectomy. Further methods provided in accordance with the present invention relate to differentiating between a malignant prostate carcinoma tissue and a non-malignant tissue and diagnosing metastasizing prostate carcinoma in a subject. Also provided are devices for carrying out the aforementioned methods. |
| priorityDate |
2012-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |